−0.1 ILS
−3.88 M ILS
876.00 K ILS
About NEXTAGE THERAPEUTI
Sector
CEO
Abraham Dreazen
Headquarters
Ness Ziona
Website
Founded
1982
ISIN
IL0004330119
FIGI
BBG000G20685
NEXTAGE Therapeutics Ltd. operates as a global pharmaceutical company. It engages in the development of cannabinoid-based products. The company was founded on May 18, 1982 and is headquartered in Ness Ziona, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NXTG is 77.3 ILA — it has increased by 6.18% in the past 24 hours. Watch NEXTAGE THERAPEUTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange NEXTAGE THERAPEUTI stocks are traded under the ticker NXTG.
NXTG stock has risen by 3.20% compared to the previous week, the month change is a 5.31% rise, over the last year NEXTAGE THERAPEUTI has showed a 123.41% increase.
NXTG reached its all-time high on Feb 2, 2021 with the price of 600.0 ILA, and its all-time low was 25.6 ILA and was reached on Jun 6, 2023. View more price dynamics on NXTG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NXTG stock is 9.03% volatile and has beta coefficient of −1.74. Track NEXTAGE THERAPEUTI stock price on the chart and check out the list of the most volatile stocks — is NEXTAGE THERAPEUTI there?
Today NEXTAGE THERAPEUTI has the market capitalization of 26.05 M, it has increased by 0.67% over the last week.
Yes, you can track NEXTAGE THERAPEUTI financials in yearly and quarterly reports right on TradingView.
NXTG net income for the last half-year is −1.72 M ILS, while the previous report showed −1.64 M ILS of net income which accounts for −4.76% change. Track more NEXTAGE THERAPEUTI financial stats to get the full picture.
No, NXTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 31.00 employees. See our rating of the largest employees — is NEXTAGE THERAPEUTI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEXTAGE THERAPEUTI EBITDA is −3.08 M ILS, and current EBITDA margin is −440.53%. See more stats in NEXTAGE THERAPEUTI financial statements.
Like other stocks, NXTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXTAGE THERAPEUTI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXTAGE THERAPEUTI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXTAGE THERAPEUTI stock shows the buy signal. See more of NEXTAGE THERAPEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.